Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker NVCR
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 9, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 29, 2026 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 1, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 9, 2026 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 1, 2026 | NVCR NovoCure Limited | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 23, 2026 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 30, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 18, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 5, 2026 | NVCR NovoCure Limited | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 5, 2026 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 30, 2026 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 24, 2026 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Apr 9, 2026 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 26, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2026 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 24, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 11, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 5, 2026 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 1, 2025 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 1, 2025 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 30, 2025 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 15, 2025 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 28, 2025 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 24, 2025 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 6, 2025 | NVCR NovoCure Limited | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 6, 2025 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 2, 2025 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 24, 2025 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 22, 2025 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2025 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 17, 2024 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Dec 2, 2024 | NVCR NovoCure Limited | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 30, 2024 | NVCR NovoCure Limited | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 30, 2024 | NVCR NovoCure Limited | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
36 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances